MEDICINOVA, INC.: 10-Q filed 2018-07-23
What MEDICINOVA, INC. reported in its quarterly report filed 2018-07-23 (fiscal Q2 2018): 30 published measures, 80 facts as tagged in accession 0001564590-18-017198.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2018-07-23
- Fiscal period
- fiscal Q2 2018
- Accession
- 0001564590-18-017198 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MEDICINOVA, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 79,076,687 | USD | |
| At 2017-12-31 | 43,419,064 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 3,487,784 | USD | |
| At 2017-12-31 | 4,776,924 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 75,588,903 | USD | |
| At 2017-12-31 | 38,642,140 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 64,162,778 | USD | |
| At 2017-12-31 | 27,991,743 | USD | |
| At 2017-06-30 | 22,890,047 | USD | |
| At 2016-12-31 | 24,118,037 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | -3,144,139 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -7,687,190 | USD | 181 |
| 2017-04-01 to 2017-06-30 | -2,788,637 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -5,805,161 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-06-30 | -5,734,761 | USD | 181 |
| 2017-01-01 to 2017-06-30 | -3,958,519 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-06-30 | 10,207 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-06-30 | 41,278,499 | USD | 181 |
| 2017-01-01 to 2017-06-30 | 2,730,250 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-06-30 | 626,317 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | -349,143,390 | USD | |
| At 2017-12-31 | -341,456,200 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 1,907 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 1,907 | USD | 181 |
| 2017-04-01 to 2017-06-30 | 2,030 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 6,090 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 59,689 | USD | |
| At 2017-12-31 | 62,886 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 800,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 3,353,637 | USD | 181 |
| 2017-04-01 to 2017-06-30 | 700,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 1,928,039 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | -3,400,282 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -8,066,863 | USD | 181 |
| 2017-04-01 to 2017-06-30 | -2,804,988 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -5,828,510 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 64,605,800 | USD | |
| At 2017-12-31 | 28,328,323 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 1,568,145 | USD | |
| At 2017-12-31 | 2,880,969 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 351,866 | USD | |
| At 2017-12-31 | 1,520,225 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 9,600,240 | USD | |
| At 2017-12-31 | 9,600,240 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 3,400,282 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 8,066,863 | USD | 181 |
| 2017-04-01 to 2017-06-30 | 2,804,988 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 5,828,510 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 1,300,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 2,900,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | 800,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 1,700,000 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 41,879,073 | shares | |
| At 2017-12-31 | 36,452,893 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | -92,806 | USD | |
| At 2017-12-31 | -94,623 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 10,958 | USD | |
| At 2017-12-31 | 10,958 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 1,216,279 | USD | |
| At 2017-12-31 | 1,360,744 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 443,022 | USD | |
| At 2017-12-31 | 336,580 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | -3,142,232 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -7,685,283 | USD | 181 |
| 2017-04-01 to 2017-06-30 | -2,786,607 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -5,799,071 | USD | 181 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | -3,148,152 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -7,685,373 | USD | 181 |
| 2017-04-01 to 2017-06-30 | -2,789,138 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -5,803,946 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 2,020,828 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 5,025,563 | USD | 181 |
| 2017-04-01 to 2017-06-30 | 1,907,780 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 4,030,641 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-06-30 | 13,479 | USD | 181 |
| 2017-01-01 to 2017-06-30 | 14,454 | USD | 181 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 7,819 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 4 | USD | 181 |
| 2017-04-01 to 2017-06-30 | -6,027 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -10,474 | USD | 181 |
Inspect the source
- Entity
- MEDICINOVA, INC. / CIK 0001226616
- Captured
- 2026-09-20T07:46:14.294Z
- SEC response SHA-256
2ee4e761c5c78942e5c8408ca3fc8acae481ff5fcfadf88ffba53700bd842714
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001226616.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))